References
[1] Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L: HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation 2014; 130:94-125.
[2] Matthews JC, Betley D, Morady F, Pelosi F, Jr.: Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2007; 18:1107-1108.
[3] Jacob S, Cherian PK, Ghumman WS, Das MK: ”Pseudo” Faraday cage: a solution for telemetry link interaction between a left ventricular assist device and an implantable cardioverter defibrillator. J Interv Card Electrophysiol 2010; 28:221-225.
[4] Oswald H, Klein G, Struber M, Gardiwal A: Implantable defibrillator with left ventricular assist device compatibility. Interact Cardiovasc Thorac Surg 2009; 8:579-580.
[5] Murphy M, Welch T, Shaw PW, Kennedy JLW, Bilchick KC: Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device. HeartRhythm Case Rep 2016; 2:473-477.
[6] Netzler PC, Vasuki N, Peura JL, Gold MR: Interactions between a left ventricular assist device and implantable cardioverter-defibrillator. Pacing Clin Electrophysiol 2012; 35:e272-273.
[7] Sehatbakhsh S, Kushnir A, Chait R, Ghumman W: Electromagnetic Interference between Subcutaneous ICD and HeartMate II LVAD. Journal of Cardiac Failure 2018; 24:S12.
[8] Erqou S, Kormos RL, Wang NC, McNamara DM, Bazaz R: Electromagnetic Interference from Left Ventricular Assist Device (LVAD) Inhibiting the Pacing Function of an Implantable Cardioverter-Defibrillator (ICD) Device. Case Rep Cardiol 2018; 2018:6195045.
[9] Mozes A, DeNofrio D, Pham DT, Homoud MK: Inappropriate implantable cardioverter-defibrillator therapy due to electromagnetic interference in patient with a HeartWare HVAD left ventricular assist device. Heart Rhythm 2011; 8:778-780.
[10] Saeed D, Albert A, Westenfeld R, Maxhera B, Gramsch-Zabel H, O’Connor S, Lichtenberg A, Winter J: Left ventricular assist device in a patient with a concomitant subcutaneous implantable cardioverter defibrillator. Circ Arrhythm Electrophysiol 2013; 6:e32-33.
[11] Ahmed AS, Patel PJ, Bagga S, Gilge JL, Schleeter T, Lakhani BA, Ravichandran AK, Donnelley S, Allavatam V, Prystowsky EN, Padanilam BJ: Troubleshooting electromagnetic interference in a patient with centrifugal flow left ventricular assist device and subcutaneous implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2018; 29:477-481.
[12] Chhabra L, Hiendlmayr B, Kluger J: An Adverse Electrophysiological Interaction Between an Implantable Cardioverter-Defibrillator and a Ventricular Assist Device. Connecticut medicine 2015; 79:351-354.
[13] Lopez-Gil M, Fontenla A, Delgado JF, Rodriguez-Munoz D: Subcutaneous implantable cardioverter defibrillators in patients with left ventricular assist devices: case report and comprehensive review. Eur Heart J Case Rep 2019; 3.
[14] Schukro C, Schloglhofer T, Khazen C, Rohrich M, Laufer G, Zimpfer D, Wiedemann D: Influence of a fully magnetically levitated left ventricular assist device on functional interrogation of implantable cardioverter defibrillators. Clin Cardiol 2019; 42:914-918.
[15] Pfeffer TJ, Konig T, Duncker D, Michalski R, Hohmann S, Oswald H, Schmitto JD, Veltmann C: Subcutaneous Implantable Cardioverter-Defibrillator Shocks After Left Ventricular Assist Device Implantation. Circ Arrhythm Electrophysiol 2016; 9.